Skip to main content

Table 2 Results of some of the recent clinical experience with Mammosite Brachytherapy System with more than a year follow up.

From: Accelerated Partial Breast Irradiation (APBI): A review of available techniques

Author

No of cases

Median follow up interval(months)

IBF

Good/Excellent cosmesis

Benitez et al.[73]

43

65

0%

81.3%

Niehoff et al [69]

11

20

0%

n/a

Patel et al.[75]

26

48.5

0%

n/a

Vicini et al.[71]

1440

30

1.6%

95%

Chen et al.[76]

70

26.1

5.7%

n/a

Belkacemi et al. [77]

25

13

0%

84%

Voth et al.[78]

55

24

3.6%

n/a

Dragun et al. [70]

90

24

2.2%

90%

Vicini et al.[79]

1440

60

2.6%

90.6%

Jeruss et al. [74]

194$

54.4

3.1%

92%

  1. n/a data not available, IBF = ipsilateral breast failure, $ these are ductal carcinoma in situ (DCIS) patients recruited in the American Society of Breast Surgeons APBI registry trial